Healthcare providers Mayo Clinic and Cincinnati Children’s Hospital Medical Center have contributed to a $15m round closed by US-based precision medicine developer Assurex Health.
The corporates invested alongside backers including Sequoia Capital, Claremont Creek Ventures and Cross Creek Advisors, all of which took part in a $30m round also featuring CincyTech, Allos Ventures and Danmar Capital in December 2014.
Assurex’s GeneSight technology uses genomic informatics to help make medicinal treatments more precise. GeneSight was developed using technology licensed from Mayo Clinic and Cincinnati Children’s Hospital Medical Center.
Virginia C. Drosos, president and CEO of Asssurex, said: “This additional financing reinforces our commitment to deliver proven, industry-leading science and to continue to build broad, clinical adoption of GeneSight.”
The company has now raised $83.5m since it was founded in 2006. All the December 2014 investors joined Jven Capital for a $7m equity round, raised alongside $25m in debt, in May 2014.